Centre for Family Medicine, Dept of Neurobiology, Care sciences and Society, Karolinska Institutet
Huddinge, 14183, Sweden
NCT Number: NCT01732302
The purpose of this study is to determine whether an educational intervention given towards health care providers working in primary health care centers can reduce inappropriate prescribing in the elderly patient and thus reduce number and length of drug-related hospitalizations as well as number of emergency department visits in this patient group.
Looking for future studies?
Notify Me65 year and older
All sexes
Interventional
Not applicable
Huddinge, 14183, Sweden
Inappropriate medication in the elderly patient leads to substantial morbidity, possibly causing up to 20% of hospitalizations in this patient group (1). To improve prescribing and thus reduce undesired drug effects is a great challenge for doctors and nurses in primary health care.
Performance of drug utilization reviews is recommended in order to reduce the negative impact of inappropriate prescribing in the elderly. However, scientific evidence on their efficacy is lacking, especially regarding patient-related health outcomes (2,3). Most studies are carried out in inpatient care, making it difficult to draw conclusions regarding primary health care (2). Moreover, studies in this scientific field diverge regarding the content and structure of drug utilization reviews, which implies that comparison between studies becomes challenging, if not impossible.
This trial aims at educating health care providers in how to perform drug utilization reviews, and to help them implement theory into practice.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Primary health care centers (PHCC) in the intervention group will be visited twice by a pharmacist within a period of three months. At the first visit, an educational intervention will focus on two properties: on the one hand, feed-back of actual patient data of the PHCC illustrating the primary-health-care-specific characteristics of inappropriate prescribing in the elderly patient will be given. Education of relevant subjects will be given in relation to detected problems. On the other hand, a clinical routine regarding the performance of drug utilization reviews will be developed in cooperation with the health care providers. At the second visit 3 months later, the developed concept will be critically reviewed and eventually developed further.
Time frame: 9 months
Time frame: 9 months
Time frame: 9 months
Time frame: 9 months
Time frame: 9 months
Time frame: 9 months
Time frame: 9 months
polypharmacy: 5-9 drugs/patient excessive polypharmacy: 10 and more drugs/patient
Time frame: 9 months
see link
Time frame: 9 months
Time frame: 9 months
Time frame: 9 months
Karolinska Institutet
Other
Educational Intervention to Reduce Drug-related Hospitalizations and Visits in Emergency Departments in Elderly Primary Health Care Patients - a Cluster-randomized Controlled Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04553107
Adverse Drug Reaction, Chemically-Induced Disorders
Houston, Texas, United States
View Trial DetailsNCT04855578
Behavior, Chemically-Induced Disorders
Montreal, Quebec, Canada
View Trial DetailsNCT03901820
Chemically-Induced Disorders, Drug Interaction
Ciudad Autonoma de Buenos Aire, Buenos Aires F.D., Argentina
View Trial DetailsNCT04663360
Chemically-Induced Disorders, Drug-Related Side Effects and Adverse Reactions
Newport, Gwent, United Kingdom
View Trial Details